Related content

Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer

By Sverrisdottir Asgerdur  

Breast Cancer Research and Treatment, Vol. 128, Iss. 3, 2011-08 ,pp. : 755-763

Springer Publishing Company

Access to resources Recommend Favorite

Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide

By Johansson Harriet   Bonanni Bernardo   Gandini Sara   Guerrieri-Gonzaga Aliana   Cazzaniga Massimiliano   Serrano Davide   Macis Debora   Puccio Antonella   Sandri Maria   Gulisano Marcella   Formelli Franca   DeCensi Andrea  

Breast Cancer Research and Treatment, Vol. 142, Iss. 3, 2013-12 ,pp. : 569-578

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy of goserelin plus anastrozole in premenopausal women with advanced or recurrent breast cancer refractory to an LH-RH analogue with tamoxifen: Results of the JMTO BC08-01 phase II trial

By                      

Oncology Reports, Vol. 29, Iss. 5, 2013-01 ,pp. : 1707-1713

Spandidos Publications

Access to resources Recommend Favorite

Long-term follow-up of the randomized Stockholm trial on adjuvant tamoxifen among postmenopausal patients with early stage breast cancer

By Rutqvist Lars   Johansson Hemming   Group on behalf of the Stockholm Breast Cancer Study  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 133-145

Informa Healthcare

Access to resources Recommend Favorite

Tamoxifen in High-risk Premenopausal Women with Primary Breast Cancer Receiving Adjuvant Chemotherapy. Report from the Danish Breast Cancer Co-operative Group DBCG 82B Trial

By Andersson M.   Kamby C.   Jensen M.-B.   Mouridsen H.   Ejlertsen B.   Dombernowsky P.   Rose C.   Cold S.   Overgaard M.   Andersen J.   Kjaer M.  

European Journal of Cancer, Vol. 35, Iss. 12, 1999-11 ,pp. : 1659-1666

Elsevier

Access to resources Recommend Favorite